Delivery Order SPE2DR25D9202-SPE2DR26FHBR6
Award Date 2/27/26
Potential Completion Date 3/2/26
Potential Value $3.7K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a $2,192.76 delivery order to DMS Pharmaceutical Group Inc. on February 18, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for lidocaine 5% patch 30-count units. DMS Pharmaceutical Group Inc. is a woman-owned small business. The PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract supporting pharmaceutical supply to Department of Defense healthcare facilities worldwide. Place of performance is Park...
- The Defense Logistics Agency issued a $2,192.76 delivery order to DMS Pharmaceutical Group Inc. on February 24, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for Lidocaine 5% Patch 30s. PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for pharmaceutical products, biologics, and medical consumables to support Department of Defense healthcare operations globally. DMS Pharmaceutical Group Inc....
- The Defense Logistics Agency issued a $1,461.84 delivery order to DMS Pharmaceutical Group Inc. on February 20, 2026, for Lidocaine 5% Patch 30s under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for pharmaceutical products and medical consumables to support Department of Defense healthcare operations worldwide. DMS Pharmaceutical Group Inc. is a...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 20, 2026, for $21,927.60 to supply Lidocaine 5% Patch 30s, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for pharmaceutical products and medical consumables to support Department of Defense healthcare operations globally. The parent IDC, awarded to...
- The Defense Logistics Agency awarded a $1,461.84 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Lidocaine 5% Patch 30S. The award, issued on January 27, 2026, with an ultimate completion date of January 28, 2026, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $3,796.80 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Lidocaine 5% Patch 30S. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of December 15, 2025, and no set-aside designation was utilized. Performance will take place in Park Ridge, Illinois, with funding provided by the Defense...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $2,932.89 to DMS Pharmaceutical Group Inc. for Lidocaine 5% Patch 30s, with an ultimate completion date of October 20, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected without a set-aside designation, demonstrating its competitive capability in unrestricted federal procurement. The delivery order will be performed in...
- The Defense Logistics Agency awarded a $2,183.16 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Lidocaine 5% Patch 30s. This delivery order, issued on August 14, 2025, with an ultimate completion date of August 15, 2025, carries no set-aside designation and represents a standard procurement vehicle under DLA's pharmaceutical supply operations. The award leverages DMS...
- The Defense Logistics Agency awarded a delivery order valued at $3,164.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Lidocaine 5% Patch 30s. The award, made on August 21, 2025, with an ultimate completion date of August 22, 2025, was issued under a firm fixed-price contract type with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $7,733.94 to DMS Pharmaceutical Group Inc. for the supply of Lidocaine 5% Patch 30s, with an ultimate completion date of September 25, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected under a firm fixed-price contract type with no set-aside designation. The place of performance is listed as Conshohocken, Pennsylvania. This delivery order...
- SPE2DR25D9202Indefinite Delivery Contract
- SPE2DR25D9202-SPE2DR26FHBR6Delivery Order
The Defense Logistics Agency issued a $3,654.60 delivery order to DMS Pharmaceutical Group Inc. on February 27, 2026, for Lidocaine 5% Patch 30s under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). DMS Pharmaceutical Group Inc. is a woman-owned small business. The order is issued under the Defense Logistics Agency's PPV-G GEN V indefinite delivery contract, a $499.999 billion program supporting pharmaceutical supply to Department of Defense healthcare facilities worldwide through multiple regional prime vendor contractors. Place of performance is Park Ridge, IL. Ultimate completion date is March 2, 2026. The order is priced firm fixed-price with no set-aside designation.
Generated 5/29/26, 10:45 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 2/26/26 |